The GSK share price jumps 6% on positive FY 2024 results. Is

3 days ago  · The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, including sales and ...


Install CouponFollow Chrome Extension   CouponFollow Extension

6%
OFF

The GSK Share Price Jumps 6% On Positive FY 2024 Results. Is

2 weeks from now

3 days ago  · The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, including sales and ...

fool.co.uk

6%
OFF

The GSK Share Price Jumps 6% On Positive FY 2024 Results. Is It A

2 weeks from now

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results. The post The GSK share price jumps 6% on positive FY 2024 results.

msn.com

6%
OFF

The GSK Share Price Jumps 6% On Positive FY 2024 Results. Is It A …

2 weeks from now

The Motley Fool The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, …

finvestly.com

6%
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...

2 weeks from now

3 days ago  · GSK's Q4 EPS and sales beat estimates Shares jump 6% R&D investment to focus on speciality medicines Feb 5 (Reuters) - GSK (GSK.L), opens new tab launched a 2 billion …

reuters.com

9%
OFF

Q4 2024 Pre-Announcement Aide Memoire - GSK

2 weeks from now

Additional commentary on Q3 results call For FY 2024, we confirm our guidance range of 7-9% sales growth and 11-13% profit growth and expect to land broadly around the middle of these …

gsk.com

7%
OFF

Is The GSK Share Price Too Cheap To Ignore? - Fool UK

2 weeks from now

Feb 1, 2024  · The GSK share price has risen 7% in 2024, but still looks cheap to me. This Fool takes a closer look at whether now is the time to buy. ... The GSK share price jumps 6% on …

fool.co.uk

8%
OFF

GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty ...

2 weeks from now

2 days ago  · GSK PLC reported an 8% increase in sales for 2024, reaching over GBP31 billion, driven by strong growth in specialty medicines. Core operating profit rose by 13% and core …

yahoo.com

9%
OFF

GSK : Q3 2024 Results Transcript - MarketScreener.com

2 weeks from now

Nov 1, 2024  · For FY 2024, we confirm our guidance range of 7-9% sales growth and 11-13% profit growth and expect to land broadly around the middle of these ranges, notwithstanding …

marketscreener.com

6%
OFF

GSK's Share Price Increases 6% After Positive Results For FY 2024. It ...

2 weeks from now

The Motley Fool GSK’s share price rose 6% in the morning, after it published its surprisingly positive full-year 2024 results. Sales and revenue were among the metrics that exceeded …

finvestly.com

6%
OFF

GSK Beats On Q4 Earnings & Sales, Stock Up On Raised Long-Term …

2 weeks from now

3 days ago  · Shares of GSK rose nearly 6% in pre-market trading today, likely due to the encouraging long-term outlook and the buyback program. In the past year, the stock has lost …

nasdaq.com

6%
OFF

Why GSK Stock Rocketed Nearly 6% Skyward On Wednesday

2 weeks from now

Oct 9, 2024  · Price as of January 17, 2025, 4:00 p.m. ET Thanks largely to news of a crucial legal settlement, GSK ( GSK -0.03% ) was one of the better-performing big pharma stocks on …

fool.com

$2
OFF

GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …

2 weeks from now

3 days ago  · GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of …

investopedia.com

$50
OFF

GSK Surges After Bumping Its 2031 Outlook To North Of $50 Billion

2 weeks from now

2 days ago  · Specifically, GSK called for more than 40 billion pounds in 2031 sales, up from its previous outlook for north of 38 billion pounds. That translates to $50.07 billion, up from …

investors.com

14%
OFF

After Strong Q2 Results And Positive Legal News, Is GSK’s Share …

2 weeks from now

Aug 12, 2024  · GSK’s share price is down 14% from its 15 May traded high of £18.12. The key reason for this I think is investor concern over the ongoing legal action alleging a link between …

fool.co.uk

$1.34
OFF

GSK PLC 3rd Quarter Results

2 weeks from now

Oct 30, 2024  · If exchange rates were to hold at the closing rates on 30 September 2024 ($1.34/£1, €1.20/£1 and Yen 191/£1) for the rest of 2024, the estimated impact on 2024 …

advfn.com

4%
OFF

Which Is The Best Value Stock Now: AstraZeneca Or GSK?

2 weeks from now

Sep 29, 2023  · Those focused on dividend income might opt for GSK. With the share price near 1,506p, the forward-looking yield is around 4% for 2024. ... The GSK share price jumps 6% on …

fool.co.uk

12%
OFF

Down 12% Since April, The GSK Share Price Fall Looks Overdone To Me

2 weeks from now

Jun 1, 2023  · The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now? ... As the share price falls after Q3 results, DCC is still my top FTSE 100 stock to buy.

fool.co.uk

6%
OFF

After FY Results, Why Is The Easyjet Share Price Still Less Than Half ...

2 weeks from now

Nov 27, 2024  · The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now? ... Strong full-year trading and an improving outlook have propelled GSK's …

fool.co.uk

FAQs about The GSK share price jumps 6% on positive FY 2024 results. Is Coupon?

Why did the GSK share price rise 6% This Morning?

The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, including sales and revenue. The multinational pharmaceutical and biotechnology company had a tough year, with an extended drop in vaccine sales. ...

Is GSK a good stock to buy now?

The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now? Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results. Mark is an IT professional with a background in financial technology. ...

Will GSK pay a dividend in the third quarter 2024?

Further, GSK has declared a dividend for the third quarter 2024 of 15 pence per share and expects to declare a dividend of 60 pence per share for the full year 2024. In its third quarter, profit before tax plunged to 64 million pounds from 1.79 billion pounds in the previous year. ...

How did GSK plc perform in 2024?

GSK PLC (NYSE:GSK) reported an 8% increase in sales for 2024, reaching over GBP31 billion, driven by strong growth in specialty medicines. Core operating profit rose by 13% and core EPS increased by 12%, leading to two upgrades in guidance for 2024. ...

What is GSK's outlook for fiscal 2024?

Further, GSK confirmed its fiscal 2024 outlook for earnings, core profit and sales, expecting broadly around the middle of the existing ranges, and also trimmed forecast for vaccines sales. ...

What are GSK's 2024 results?

GSK's 2024 results are strong, with a promising shift toward specialty medicines, particularly in HIV, respiratory conditions, and cancer, driving long-term growth. Key drugs Blenrep and Depemokimab show significant potential, with impressive Phase 3 results, expected to boost GSK's revenues by an extra £7 billion. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension